Related Experiment Video
Updated: Aug 14, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Molecular cross-talk between the TRAIL and interferon signaling pathways
Chandan Kumar-Sinha1, Sooryanarayana Varambally, Arun Sreekumar
1Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Abstract:
TRAIL/APO-2L induces apoptosis in a variety of transformed cells and has potential as an anti-cancer therapeutic. The physiologic role of TRAIL is presumably more complex than merely activating caspase-mediated cell death. To shed light into TRAIL-mediated signaling, we used DNA microarrays to profile gene expression mediated by TRAIL in breast carcinoma cells. Primary response genes induced by TRAIL included a number of known NF-kappaB-dependent genes such as cIAP2, A20, and E-selectin. Remarkably, global transcriptome analysis revealed that TRAIL also induced a cohort of genes related to the interferon-signaling pathway. Assessing interferon-induced gene expression suggested various points of interaction with the TRAIL signaling pathway. Interestingly, while we observed interferon-mediated up-regulation of TRAIL, we also demonstrated a concomitant TRAIL-mediated induction of interferon-beta. Combining TRAIL and interferon in vitro, synergistically induced apoptosis and caspase activation in breast cancer cells. Together, these data indicate multiple levels of molecular cross-talk between the two diverse cytokines with anti-tumor properties.
Insights
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and interferon-beta synergistically enhance breast cancer cell death. This study reveals cross-talk between TRAIL and interferon signaling pathways, offering new therapeutic insights.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand) induces apoptosis in cancer cells, showing therapeutic potential.
- The full scope of TRAIL-mediated signaling extends beyond simple caspase activation.
- Understanding TRAIL's complex signaling is crucial for developing effective anti-cancer therapies.
Purpose of the Study:
- To investigate TRAIL-mediated gene expression in breast carcinoma cells using DNA microarrays.
- To elucidate the molecular interactions between TRAIL and interferon signaling pathways.
- To explore the combined therapeutic potential of TRAIL and interferon-beta in breast cancer.
Main Methods:
- DNA microarrays were employed to profile gene expression changes induced by TRAIL in breast cancer cells.
- Analysis focused on identifying primary response genes and interferon-related signaling pathways.
- In vitro experiments combined TRAIL and interferon-beta to assess synergistic effects on apoptosis and caspase activation.
Main Results:
- TRAIL induced known NF-kappaB-dependent genes (e.g., cIAP2, A20, E-selectin) and a significant cohort of interferon-signaling pathway genes.
- Evidence of molecular cross-talk was observed, including interferon-mediated upregulation of TRAIL and TRAIL-mediated induction of interferon-beta.
- Combined treatment with TRAIL and interferon-beta synergistically enhanced apoptosis and caspase activation in breast cancer cells.
Conclusions:
- TRAIL signaling in breast cancer cells involves intricate cross-talk with the interferon pathway.
- The combination of TRAIL and interferon-beta demonstrates synergistic anti-tumor activity.
- These findings highlight novel therapeutic strategies by combining TRAIL and interferon-based treatments for breast cancer.
Related Concept Videos
Intracellular Signaling Cascades
Intracellular Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
Inhibitors of Viral Protein Synthesis

